Collaborative & Service Projects

Collaborative Projects

Collaborative Project (CPs) serve to focus technology development within TR&Ds on novel and impactful challenges, while also serving as test beds to evaluate the technologies and provide feedback to the TR&Ds. This interactive relationship is fundamental to the NCBIB concept. This proposal includes 10 CPs from diverse areas of biomedicine that can benefit from novel technologies in metabolic imaging. During the course of the project, some CPs will end when their funding or technology development are completed, and new CPs will be added. Based on the P41 guidelines, “While it is expected that the vast majority or all of the CPs would have funding support in place at the time of P41 application, there is not an expectation that this funding must be in place for the entire proposed duration of the P41 funding period.”

One of the cornerstones of the NCBIB mechanism is “Working in a push-pull, iterative relationship with CPs, a TR&D project should develop and optimize new tools and methods to address specific biomedical research problems that are otherwise difficult to tackle using existing tools and methods.” In this process, CPs serve as testbeds for evaluating the NCBIB developed technologies and providing the feedback to the TR&Ds for further developments. Thus, the entire pull activity (what is returned to the NCBIB by the CP and that will be used to motivate further developments) for every technology is not knowable a priori and the pull activity (in some cases push activity also) continue to occur during the course of the interaction. Accordingly, depending upon the maturity of the collaboration, some of the CPs will have more details on push or pull than others.

The criteria for selecting collaborative projects: Many CPs derive from collaborative relationships of CAMIPM investigators or by new collaborative relationships arising from meeting and workshop presentations. Collaborative project requests can also be made on the resource website via the online Collaborate form (see Training & Dissemination section) available on the CAMIPM website. Submissions are automatically forwarded for review to the Executive Committee. New CP proposals will be presented to the Executive Committee by the PI of the relevant TR&D(s) which will review them according the following criteria:1) The project must drive innovative technical developments in at least one of the TR&Ds and serve as the test bed for evaluating the resulting technology, 2) Feasibility of achieving the proposed technology development with CAMIPM resources, 3) Feasibility of implementing the resulting technology by the CP, including availability of instrumentation, infrastructure, and funding at the CP site, and 4) Demographic diversity in the CP portfolio. New CPs will also require approval of the CAMIPM EAC, which will be obtained at annual meetings or electronically. CPs will be required to acknowledge NCBIB support on the publications resulting from collaborations regardless whether the NCBIB members are listed as authors. 4) Demographic diversity in the CP portfolio. New CPs will also require approval of the CAMIPM EAC, which will be obtained at annual meetings or electronically. CPs will be required to acknowledge NCBIB support on resulting publications regardless of NCBIB members listed as authors.

Precision of proposed metabolic measures: While “precision” in CAMIPM refers to mechanistic precision rather than measurement precision, we provide data on the precision and specificity of some the proposed technologies in Table 1 as a basis for further technological development and application of these technologies to specific disorders or interventions such as TMS and exercise.

Service Projects

Service Projects (SPs) are also a key component of the BTRC mechanism. While not serving as drivers test beds for NCBIB technology development, SPs are early adopters of validated technologies derived from the NCBIB. This CAMIPM proposal includes 10 SPs that are using metabolic imaging technologies described in our preliminary results. These include both acquisition methods and protocols as well as signal processing algorithms and software. In addition to disseminating its technologies, CAMIPM support of SPs includes access to expertise in the NCBIB for consultation in experimental design, protocol development, data analysis and data interpretation, and is some cases access to CAMIPM instrumentation.

The criteria for recruiting service projects and services to be provided by CAMIPM: The SPs are currently funded projects that utilize the matured technologies and capabilities of the proposed NCBIB to expand their research objectives. Potential service project investigators may call/email/meet directly with Executive Committee members or respective TR&D leader to discuss and initiate service projects. Formal requests will be made by applying through the online Collaborate form (see Training & Dissemination section) available on the CAMIPM website summarizing the project’s rationale, infrastructure, and plan for use of CAMIPM technology. Submissions are automatically forwarded for review to the Executive Committee. These projects should have extramural funding and meet all the criteria for collaborative projects except that they do not need to have the push-pull component. New service projects must also meet the following criteria: 1) technical feasibility, 2) clinical feasibility (if applicable), 3) clinical safety, and 4) scientific merit. Early stage or other investigators who do not have current funding and plan to acquire preliminary data for potential extramural support will be referred to Center for Advanced Magnetic Resonance Imaging and Spectroscopy (CAMRIS), the departmental committee that oversees all MRI research, for securing MRI scanner time under a paid protocol development process. Therefore, there is no chargeback mechanism proposed.  Overall, the proposed NCBIB will provide SP investigators access to the unique and advanced metabolic imaging technologies including consultation, advise on the experimental design, acquisition, analyses tools that are not available at other centers.

 

ALL Collaborative Projects carried out in the Center from 06/01/2021 to present.

Current Ongoing Projects:

C Mostoufi-Moab, Sogo Children’s Hospital of Philadelphia, PA, 1R01CA254955, 01-Sep-2021 to 31-Aug-2026

C Zamani, Payman University of Pennsylvania, PA, 1R01HL155599, 01-May-2021 to 30 to Apr-2026

C Zamani, Payman University of Pennsylvania, PA, 1R01HL157264, 01-July-2021 to 31 to May-2026

C Reddy, Ravinder University of Pennsylvania, PA, 1R01AG071725, 01-Feb-2022 to 30-Nov-2026

C Reddy, Ravinder University of Pennsylvania, PA, 1R01AG063869, 15-Apr-2020 to 31-Mar-2025

C Cheng, Zhiliang University of Pennsylvania, PA, 1R01AR080820, 01-Apr-2022 to 31-Mar-2027

C Witschey, Walter and Bravo, Paco University of Pennsylvania, PA, NIH 1R01HL169378, 01-Jul-2023 to 30-Apr-2027

C Keith St Lawrence U. Western Ontario London, ON, NIH R01 NS131235, 01-Mar-2024 to 29-Feb-2028 and 

Canadian Institute for Health Research-IRSC:180306, Apr-2022 to Mar-027

C Samuel Shin UPENN Philadelphia, PA, DOD #23TPA1142711, Sept-2023 to Aug-2026

C Walter Witschey & Paco Bravo, UPENN Philadelphia, PA, NIH 1R01HL169378, 01-Jul-2023 to 30-Apr-2027

C Regine Choe University of Rochester Rochester, NY , NIH-R01NS131967, 02-Jan-2024 to 30-Nov-2028

C Manoj Kumar National Institute of Mental Health and Neuro-Sciences, (NIMHANS), Bangaluru, India File No. CRG/2021/000668, 01-Jul-2024 to 30-Jun-2027

C Manoj Kumar National Institute of Mental Health and Neuro-Sciences, (NIMHANS), Bangaluru, India, EM/Dev/SG/216/0967/2023, 01-Jul-2024 to 30-Jun-2027

C Ravinder Reddy UPENN Philadelphia, PA, 1U01AG089107, 15-Aug-2024 to 31-Jul-2029

C Mohammad Haris UPENN Philadelphia, PA, 1U01AG0960, 15-Dec-2024to 30-Nov-2029

C Corinde Wiers & Ravi Nanga, UPENN Philadelphia, PA, 1R21AA031088, 01-Jun-2024 to 31-May-2026

C Corinde Wiers & Ravi Nanga, UPENN Philadelphia, PA, 1U01AG0960, 15-Dec-2024 to 30-Nov-2029

Past Expired Projects:

P Farrar, Christian Massachusetts General Hospital MA, 5R01CA203873, 15-May-2016 30 to Apr-2023

P Balchandani, Priti Icahn School of Medicine at Mount Sinai, New York NY, 5R01MH109544, 23-Sep-2016 to 30-Jun 2022

P Forbes, Sean, University of Florida, FL, R01 AR070101, 9/20/2016 to 07/31/2022

P Smart, DeeDee Radiation Oncology Branch, NCI/NIH MD Z01# ZIA BC 011790-0206 Nov-2018 to 06-Nov-2022

P Loggia, Marco & Ratai, Eva-Maria Massachusetts General Hospital MA 1R01DA047088 15-Jul-2018 to 31-Jul-2024

P Wang, Danny JJ University of Southern California CA 4UH3NS100614 30-Sept-2016 to 30-Jun-2021

P Wise, Richard Cardiff University Brain Research Imaging Centre (CUBRIC) Canada Italian “Ministry of Universities and Research”

P Witschey, Walter University of Pennsylvania PA 1R01HL137984 01-Jun-2018 31 to Mar-2024

P Coslett, H Branch University of Pennsylvania PA 1R01DC016800 14-Sep-2018 31 to Aug-2023

P Buckley, Erin Emory University/GA Tech GA DOD/CDMRP (W81XWH- 18-1-0669) 15-Sept-2018 to 14-Sept-2022

P Hardy, Peter University of Kentucky KY 5R01AR071398 22-Jul-2017 to 30-Jun-2024

P Baur, Joseph andcReddy, Ravinder, University of Pennsylvania, PA, FARA Funding, 01-Aug-2022 to 31-Jul-2024

P Baur, Joseph and McCormack, Shana, University of Pennsylvania/Children’s Hospital of Philadelphia, PA, Calico, LLC, 17-Apr-2023 to 16-Apr-2025

P Erin Englund U. Colorado Denver, Anschutz, Denver, CO, NIH- AHA853697, 01-Jul-2021 to 30-Jun-2024 and  NIH/NCATS Colorado, CTSA Grant KL2TR002534, 01-Nov-2021 to 31-Oct-2024

P Todd Kilbaugh Children’s Hospital of Philadelphia, Philadelphia, PA Toyota Forward Way Fund, 01-Mar-2023 to 31 Mar-2025

P Erin Englund U. Colorado Denver, Anschutz, Denver, CO, NIH- AHA853697, 01-Jul-2021 to 30-Jun-2024 and  NIH/NCATS Colorado, CTSA Grant KL2TR002534, 01-Nov-2021 to 31-Oct-2024

ALL Service Projects carried out in the Center from 06/01/2021 to present.

Current Ongoing Projects:

C Keith St. Lawrence, Lawson Health Research Institute Canada Canadian Institutes of Health Research, 01-Apr-2022 to 31-Mar-2027

C Ravinder Reddy, University of Pennsylvania, PA, R01 AG063869, 01-April-2020 to 31-March-2026

C David Roalf,  University of Pennsylvania, PA R01 MH120174, 01-July-2020 to 30-June-2025

C Turgut Durduran,  ICFO Barcelona, Spain,  PLEC2022-009290, MCIN/AEI/10.13039/501100011033, European Union NextGeneration EU/PRTR, Dec-2022 to Nov-2025

C Turgut Durduran, ICFO Barcelona, Spain, Safe ICP MCIN/AEI European Union PLEC2022009290 European Union Next Generation EU, 01-Dec-2022 to 30-Nov-2025

C Andrew Anderson, University of Utah, UT, NIH 1R21AR083686, 17-Jan-2024 to 31-Dec-025

C Ze Wang, University of Maryland, Baltimore, MD, NIH R01 AG070227, Aug-2021 to Apr-2025

C Thomas Liu, UCSD Center for Functional MRI, CA,  Psychedelic Exploration Gift Fund, The Steven & Alexandra Cohen Foundation, 01-Jan-2025 to 31-Dec-2027

C Jon Dean, UCSD Center for Psychedelic Research CA, Psychedelic Exploration Gift Fund, 01-Jan-2025 to 31-Dec-2027

C Axel Carl Gottfrid Nyman, Norwegian University of Science & Technology (NTNU), Norway NTNU Biotechnology Grant, 15-Jun-2023 to 31-Dec-2025

Past Expired Projects:

P Delia Talos, University of Pennsylvania, PA, 1R01NS101156, 15-May-2018 to 31-Mar-2023

P Vitaly Napadow & Bruce Rosen, Massachusetts General Hospital, MA, 1P01AT009965, 01-Aug-2018 to 31-Jul-2023

P Shana McCormack, Children’s Hospital of Philadelphia, PA, R01 HL149722, 01-Jan-2020 to 31-Dec-2024

P Yvette Sheline, University of Pennsylvania, PA, 5R01MH110939, 05-Jun-2017 to 31-Mar-2023

P Seda Tierney, Stanford University, CA, R61 HL146775, 10-Mar-2020 to 28-Feb-2024

P Daret St. Clair, (PI) and Guogiang Yu (Co-I), University of Kentucky, KY, COBRE # 5P20GM121327, 01-Mar-2017 to 31-Dec-2021

P Christopher Favila, UPENN, PA, NIH R21 NS131235, 04/01/2022 to 03/31/2024 and NIH R21 EB031364, 01-Mar-2022 to 31-Dec-2024

P Evangelia Chrysikou, Drexel University, PA, National Center of Neuromodulation for Rehabilitation, 01-Feb-2021 to 31-Jan-2025